Effect of Plasma Rich in Growth Factors in Rotator Cuff Tendinopathy
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
The overall objective of the study is to assess the effectiveness of the treatment of
degenerative rotator cuff tendinopathy using the application of plasma rich in growth factors
(PRGF).
Main objective:
To show more effectiveness after 6 months of treatment with PRGF, with an improvement in the
reference test of more than 15% compared to the treatment with corticosteroids.
Secondary objective:
- To assess the efficacy of the treatment after 12 months.
- Quantification of platelet levels in patients treated with plasma rich in growth factors
and its correlation with the clinical effect.
Phase:
Phase 3
Details
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias